Texas residents should know that not all cancers are readily identifiable. Medical professionals have had a hard time studying certain rare tumors; the relative lack of patients to analyze means that most data comes from individual case reports rather than clinical trials. Besides that, few professionals are even focused on these conditions. The result is that patients with rare cancers are frequently misdiagnosed.
One growing way to treat rare tumors
Most cancers are treated based on where they originate in the body, but experts can increasingly treat rare cancers by focusing on the genetic mutations that cause them. For example, there are immunotherapy drugs that can treat cancers where the DNA in the tumor cannot properly repair itself: what’s called a mismatch repair deficiency.
These drugs, then, can treat rare conditions like rhabdomyosarcoma along with the more well-known colorectal, breast and prostate cancers. Other drugs can target both rare and common cancers that exhibit NTRK gene fusions. Small biotechnology companies have plenty of incentives, too, in coming up with drugs for particular cancers and carving out their own niche.
The beneficial use of patient registries
With patient registries, doctors have access to both patients’ self-reported data and their clinical information. One advantage to these is that they assemble the data on a large group of patients without the hassles of a clinical trial, facilitating research.
When victims of diagnostic errors can do
The rarity of a condition is not the only reason for misdiagnoses and delayed diagnoses as, sometimes, doctors may miss something out of sheer negligence. If this has happened to you, you may have a case under medical malpractice law. With an attorney by your side, you could strive for a fair settlement that covers your medical expenses, lost wages and other losses. As a last resort, the attorney may assist with litigation.